Fundies.
English

Segment disclosures

Company overview

CARIS LIFE SCIENCES, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

3 dimension combinations 25 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Molecular Profiling Services · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cai:MolecularProfilingServicesMember;us-gaap:StatementBusinessSegmentsAxis=cai:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31766719000 USD20260303Open filing evidence
2025-07-01 – 2025-09-30207587000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30484593000 USD20251105Open filing evidence
2024-01-01 – 2024-12-31349115000 USD20260303Open filing evidence
2024-07-01 – 2024-09-3093803000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30254692000 USD20251105Open filing evidence
2023-01-01 – 2023-12-31278748000 USD20260303Open filing evidence

Pharma Research And Development Services · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cai:PharmaResearchAndDevelopmentServicesMember;us-gaap:StatementBusinessSegmentsAxis=cai:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3145314000 USD20260303Open filing evidence
2025-07-01 – 2025-09-309246000 USD20251105Open filing evidence
2025-01-01 – 2025-09-3034554000 USD20251105Open filing evidence
2024-01-01 – 2024-12-3163145000 USD20260303Open filing evidence
2024-07-01 – 2024-09-307817000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3027653000 USD20251105Open filing evidence
2023-01-01 – 2023-12-3127380000 USD20260303Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cai:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31812033000 USD20260303Open filing evidence
2025-07-01 – 2025-09-30216833000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30519147000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30181398000 USD20250812Open filing evidence
2025-01-01 – 2025-06-30302314000 USD20250812Open filing evidence
2024-01-01 – 2024-12-31412260000 USD20260303Open filing evidence
2024-07-01 – 2024-09-30101620000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30282345000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30100049000 USD20250812Open filing evidence
2024-01-01 – 2024-06-30180727000 USD20250812Open filing evidence
2023-01-01 – 2023-12-31306128000 USD20260303Open filing evidence